Brugts JJ, Radhoe SP, Clephas PRD, et al
E.Van Den BergL
So the commonly cited regain curves reflect a very specific scenario: Sudden withdrawal of potent appetite-regulating therapy Removal of dietary, physical activity, and behavioral scaffolding that supported weight loss during the trial phase That combination almost guarantees weight regain and tells us more about biology plus trial design than about real-world inevitability
Dietary Gaps Individuals who eat little or no B12-rich foods like meat, fish, eggs, or dairy have a much greater risk of developing a deficiency
Weiner: Can you provide some tips or insights into safely using SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabetes
These compounds are believed to work synergistically on cellular lipid mobilization, though clinical evidence remains mixed and outcomes vary widely among individuals